Acute kidney injury - Patients who received all of the AQ bundle as part of the AQ programme spent 1.3 less days in hospital. For more information contact [email protected]

By using validated patient data from our participating trusts, the #AQ programme is able to evaluate improvement work over time, providing our members with a robust measurement for improvement approach! Get in touch to find out more: [email protected]

Decompensated liver disease - AQ supports high-quality care and better outcomes for this overlooked but challenging group of patients, who have high levels of socioeconomic deprivation. For more information contact [email protected]

Did you know that the AQ programme is part of the wonderful Aqua NHS and supports acute trusts from across the North West to collect high quality patient data to improve clinical care. Get in touch to find out more [email protected]

Community acquired pneumonia - 1 in 3 patients coded as pneumonia don’t have pneumonia. The clear picture AQ’s uniquely validated data provides equips clinicians to improve care. For more information contact [email protected]

Hospital-acquired pneumonia accounts for 15,000 additional bed days in the northwest every year, at a cost of least £30 million. AQ works with providers, for information: [email protected]

Clinical focus areas supported by the AQ programme include: - Sepsis - Community Acquired Pneumonia (CAP) - Hospital Acquired Pneumonia (HAP) - Hip & Knee Replacement - Acute Kidney Injury (AKI) - Decompensated Liver Disease (DLD)

Acute kidney injury - Patients who received all of the AQ bundle as part of the AQ programme spent 1.3 less days in hospital.

Our data process looks a bit like this… Want to know more? Get in touch: [email protected]

Our monthly reports keep trusts up to date with how they’re performing in our 6 clinical focus areas, showing where they’re doing well and where they could improve. The reports are based on our validated dataset, to give a clearer picture than you get from standard NHS data

Decompensated liver disease AQ supports high-quality care and better outcomes for this overlooked but challenging group of patients, who have high levels of socioeconomic deprivation.

Did you know, in 1 year AQ affects the direct treatment of around 10,000 patients, representing about 5% of emergency admissions. We are continuously working with the AQ community to support improvement for these patients.

Clinical focus areas supported by the AQ programme include: - Sepsis - Community Acquired Pneumonia (CAP) - Hospital Acquired Pneumonia (HAP) - Hip & Knee Replacement - Acute Kidney Injury (AKI) - Decompensated Liver Disease (DLD)

Our monthly reports keep trusts up to date with how they’re performing in our 6 clinical focus areas, showing where they’re doing well and where they could improve. The reports are based on our validated dataset, to give a clearer picture than you get from standard NHS data

Decompensated liver disease - AQ supports high-quality care and better outcomes for this overlooked but challenging group of patients, who have high levels of socioeconomic deprivation.

Did you know, in 1 year AQ affects the direct treatment of around 10,000 patients, representing about 5% of emergency admissions. We are continuously working with the AQ community to support improvement for these patients.

Community acquired pneumonia - 1 in 3 patients coded as pneumonia don’t have pneumonia. The clear picture AQ’s uniquely validated data provides equips clinicians to improve care.

The AQ programme provides a foundation to your evidence based change and improvement initiatives. For more information visit aqua.nhs.uk/solutions/aq-p…

Advancing Quality’s measure sets are consensus-based and clinically endorsed. They define what high-quality care looks like. For more information contact: [email protected]

AQ data is of the highest quality. Validation ensures that comparisons over time and between places reflect clinical variation rather than different approaches to coding and documentation #improvement #AQ #QI #data